gMendel® establishes Board of Directors and announces Appointments November 15, 2022, Copenhagen – gMendel® announced today its first Board of Directors. The company is also pleased to announce the appointments of Lars Staal Wegner, Chairman, and Hanna Pyokari,...
Meet Areti Areti is a 28-year-old young woman suffering from spinal muscular atrophy (SMA) type 2, a severe neurological disease that leads to gradual weakness and atrophy of the muscles, which destroys the patient’s motor skills. For the last three years,...
Meet Anastasia Anastasia was in an artificial coma for 32 days, before she woke up. That made her the first Greek woman with cystic fibrosis who woke up from a coma and the first ever person who woke up after such a long coma, globally. In total, Anastasia endured:...
gMendel® and genXone join forces in diagnosis of genetic disorders. 27 September, 2022 – Copenhagen – gMendel® has signed a letter of intent to significantly expand its cooperation with Polish biotech company genXone. The two companies joined efforts...
Fragile x What is Fragile X?Fragile X syndrome (FSX) is the most frequent inherited form of intellectual disability. The disorder is caused by an expansion of a trinucleotide segment (CGG) in the Fragile X Mental Retardation-1 gene (FMR1) located in the X...
Recent Comments